1. Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Comparison of ATPIII and IDF classifications
Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Comparison of ATPIII and IDF classifications. The label on the right side of each line represents the corresponding MS status, “ATPIII” stands for MS classified according to the Adult Treatment Panel III. “IDF” stands for MS classified using the International Diabetes Federation. In the second row of the label, number of events/number of subjects in the group. X-axis = years of follow-up. Y-axis = proportion of subjects free of CV events. Inside panel = hazard ratios of MS groups vs. the respective non-MS groups by the Cox model (age and gender adjusted) and 95th confidence intervals in brackets.
Noto D, et al. Atherosclerosis 2008;197:147-53

2. Clinical and biochemical parameters in the study population
Noto D, et al. Atherosclerosis 2008;197:147-53

3. Prevalence of cardiovascular risk factors in the study population
Noto D, et al. Atherosclerosis 2008;197:147-53

4. 15 years cumulative incidences and hazard ratios for CV events in metabolic syndromea (primary and secondary endpoints)
Noto D, et al. Atherosclerosis 2008;197:147-53

5. Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Survival according to Metabolic Syndrome and impaired fasting blood glucose/diabetes mellitus
Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Survival according to Metabolic Syndrome and impaired fasting
blood glucose/diabetes mellitus. The label on the right side of each line represents the corresponding MS/FBG status, “IFG” stands for Fasting Blood glucose ≥110 mg/dL (6.11 mmol/L) or Diabetes Mellitus. In the second row of the label, number of events/number of subjects in the group. X-axis = years of follow-up. Y-axis = proportion of subjects free of CV events. Inside panel = hazard ratios of MS groups vs. non-MS group by the Cox model (age and gender adjusted) and 95th confidence intervals in brackets. No survival is shown for the “no MS/IFG” group since few events/cases (7/34) were recorded in this group. No significant differences in the estimated survival probabilities were found between the MS subjects with/without IFG by the Cox model.
Noto D, et al. Atherosclerosis 2008;197:147-53